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Abstract
In this study, the frequencies of CYP1A1, GSTM1, and GSTT1 gene polymorphisms were determined in 133 healthy
individuals from Ouangolodougou, a small rural town situated in the north of the Ivory Coast. As appeared in several
published studies, ethnic differences in these frequencies have been found to play an important role in the metabo-
lism of a relevant number of human carcinogens. In the studied sample, the frequencies of Ile/Ile (wild type), Ile/Val
(heterozygous variant), and Val/Val (homozygous variant) CYP1A1 genotypes were 0.271, 0.692, and 0.037, re-
spectively. Frequencies of GSTM1 and GSTT1 null genotypes were 0.361 and 0.331, respectively. No significant dif-
ferences were noted between men and women. In contrast to published data for Africans, CYP1A1 *Val Allele
frequency (0.383) was significantly high (p < 0.001) in this specific population. For the GSTT1 null genotype, no dif-
ferences were found between the studied and other African populations, the contrary to what occurred for the
GSTM1 null genotype in relation to Gambia and Egypt.
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Several polymorphic genetic systems have been used
to study human genetic variation. Herein we report for a
sample from the Ivory Coast on the frequencies of three
polymorphic metabolic genes that have been found to play
animportantroleinthemetabolismofarelevantnumberof
human carcinogens: the Cytochrome P450 1A1 (CYP1A1),
the Glutathione S-transferases (GST) T1 and the GSTM1
genes. Several published studies pointed to ethnic differ-
ences in the frequencies of gene polymorphisms, shown to
be associated with several types of cancer. The CYP1A1
gene is a component of the phase I cytochrome P450 super-
family, which plays a primary role in the metabolism of
polycyclic aromatic hydrocarbons. Its gene product cataly-
ses the first step in the conversion of several environmental
carcinogens into their ultimate DNA-binding carcinogenic
form(forareviewseeIndulskiandLutz,2000).Thehuman
CYP1A1 gene is highly polymorphic. In certain popula-
tions, such as the Japanese and Chinese, the amino acid
substitution CYP1A1 Ile(462)Val has been reported to be
associated with a higher risk of certain types of cancer, as
lung cancer (Chen et al., 2001), although in other popula-
tions, evidence of this association lacks support (McGrath
etal.,2007).Thesecontradictoryresultscouldbeexplained
bythedistinctgeneticbackgroundsoftheinvestigatedpop-
ulations, as well as other non-genetic factors.
Glutathione S-transferases, found in virtually all
eukaryotes, represent one of the major groups of phase II
detoxifying enzymes, having evolved to provide organic
protection against toxic substances present in food and the
environment (Nebert et al., 1996). The mechanism in-
volves the binding of glutathione to insoluble electrophilic
substrates, thereby converting them into a soluble form
(Perera, 1997). GSTT1 and GSTM1 genes have long been
known to be polymorphic in humans by the deletion of a
segment of DNA, with the subsequent lack of protein syn-
thesisinhomozygousindividuals.Asaresultofdeletionsat
either of the two loci, and the consequent reduced detoxifi-
cation of xenobiotics, an individual may become suscepti-
ble to diseases produced by toxic substances present in the
environment (Roy et al., 2001). Deletion polymorphism in
GSTgenes(non-functionalalleles)hasbeenfoundtobeas-
sociated with the development of certain types of cancer,
such as oral cancer (Cha et al., 2007), chronic myeloid leu-
kaemia (Bajpai et al., 2007), bladder cancer (Ouerhani et
al., 2006), and colon cancer (Gertig et al., 1998). Although
variabilityinthedistributionofGSTM1andGSTT1nullge-
notypes has been reported in diverse ethnic groups (Nelson
etal.,1995;Garteetal.,2001),sparsedataareavailablefor
West Africa (Wild et al., 2000). The aim herein was to in-
vestigate the genetic variability at CYP1A1 and GSTs loci
inanAfricanpopulationfromtheIvoryCoast,forwhichno
data has been published to date on metabolic gene poly-
morphisms.
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Short CommunicationSampling was undertaken in Ouangolodougou, a
small rural town of 20,000 inhabitants located in the north
IvoryCoast,thisrepresentingthelastfrontierzonebetween
the Ivory Coast, Mali and Burkina Faso. One hundred and
thirty-threeindividuals(62malesand71females,meanage
31.9  14,5) were analyzed. All were healthy volunteers
and had received prior information regarding the study.
Peripheral blood samples (5-10 mL venipuncture)
were collected in heparinized vacutainers and stored at
-20 °C. The Chelex
® solution protocol was used to extract
DNA, as described by Walsh et al. (1991). GSTM, GSTT1
and CYP1A1 genotypes were defined by polymerase chain
reaction (PCR), using primers and reaction profiles as de-
scribed by Zhong et al. (1993), Pemble et al. (1994) and
Chen et al. (2001), respectively. PCR reactions were car-
riedoutinatotalvolumeof25Lcontaining10ngofDNA
(template), with a final concentration of 1X Reaction
Buffer, 1.5 mM of MgCl2, 5% of DMSO, 250 Mo f
dNTPs, 0.5 M of each primer, and 1 U/sample of Taq
DNApolymerase(Fischer,U.S.).PCRproductsweresepa-
ratedbyelectrophoresisona3%agarosegelandvisualized
by ethidium bromide staining. The expected size of ampli-
fied CYP1A1 products was 162 base pairs (bp), whereas in
the case of GSTM1, GSTT1 and -globine (used as internal
control), the expected sizes were 230, 480 and 110 bp, re-
spectively. Homozygous null genotypes of GSTM1 and
GSTT1 were determined by identifying the negative band
for each size (with the simultaneous presence of the posi-
tive control), whereas positive bands meant the sample was
homo- or heterozygous for the indicated alleles. A geno-
typewithhomozygousdeletionoftheGSTgenesisdenom-
inated “GST-null”, whereas a genotype having at least one
copy of the gene is “GST-positive”. In order to validate the
obtainedresults,about20%ofthetotalsample(n=30)was
genotyped independently by a second researcher.
Allele and genotype frequencies of the CYP1A1 gene
were calculated using GENEPOP Version 4.0 (Raymond
and Rousset, 1995). Hardy-Weinberg equilibrium (HWE)
and comparisons among age-groups were evaluated by the
Chi-square (
2) test with a 95% confidence interval.
Observedallelefrequencieswerealsocomparedwiththose
reportedforotherpopulationsworldwide,throughtheanal-
ysis of contingency tables also by 
2-testing.
The frequencies of CYP1A1 and GSTs allelic poly-
morphisms in a sample from the north Ivory Coast popula-
tion, were analyzed. No significant differences were found
between men and women in the allele frequency of each
gene (p > 0.05), thus possibly implying the absence of dif-
ferences by sex in these detoxifying enzymes.
TheobservedfrequenciesoftheCYP1A1Ile/Ile(wild
type), Ile/Val (heterozygous variant) and Val/Val (homo-
zygous variant) genotypes were 0.271, 0.692, and 0.037,
respectively (Table 1). Differences in CYP1A1 allele fre-
quency distribution were reported among various ethnic
groups (Garte, 1998; Garte et al., 2001). In the studied
Ivory Coast population, *Val allele frequency was signifi-
cantly(p<0.001)high(0.383),ascomparedtothefewdata
published for Africans (Table 2). This difference in
CYP1A1 polymorphism distribution among Africans could
probably be attributed to the different evolutionary histo-
ries of the studied ethnic groups, although, as this polymor-
phism is not neutral, the distinctive selective pressure
exertedbychemicalsondifferentpopulationscannotbeex-
cluded. The high heterozygosity frequency value found for
CYP1A1 gene (0.692) is congruent with many global sur-
veys of genetic markers, these indicating that diversity in
African populations is consistently greater than in other
populations (Garrigan and Hammer, 2006). On the other
hand, the excess of heterozygotes gave rise to a deviation
from HWE (p < 0.05). Moreover, a selective pressure ex-
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Table 1 - Genotype and allele Frequencies at CYP1A1 and GSTs loci in the Ouangolodougou population (n = 133)
Genotype Observed subjects (frequency) Expected subjects (frequency) 
2 (1 d.f.) Allele (frequency)
CYP1A1
Ile/Ile 36 (0.271) 51 (0.383) 4.41 Ile (0.617)
Ile/Val 92 (0.692) 63 (0.474) 13.35 Val (0.383)
Val/Val 5 (0.037) 19 (0.143) 10.32
Total 28.08
GSTM1
Present 85 (0.639)
Null 48 (0.361)
GSTT1
Present 89 (0.669)
Null 44 (0.331)
GSTM1 null and GSTT1 null 19 (0.143)
n = number of tested individuals.ertedbyxenobioticsonthispopulationcannotbeexcluded.
Although this possibility is consistent with several studies
showing the association of this polymorphic gene with risk
factors for diseases (Chen et al., 2001), convincing evi-
dencetosuggestaroleofthesepolymorphismsinmodulat-
ingsusceptibilitytocancerdiseases,islacking(McGrathet
al., 2007).
Differences in GSTT1 and GSTM1 frequencies in
populations worldwide have already been described (Nel-
sonetal.,1995;Garteetal.,2001).Thesedifferencesshow
that GST genotype frequencies are distributed population-
wise according to the various ethnic and geographical pat-
terns (Garte et al., 2001; Hatagima et al., 2004). In our
sample, the frequencies of GSTM1 and GSTT1 null geno-
types were 0.361 and 0.331 respectively, whereas the fre-
quency of individuals lacking both genes was 0.143
(Table 1). GST genotypes were coded as positive (wild-t-
ype homozygotes and deletion heterozygotes) or null (ho-
mozygous deletion), thereby making direct calculation of
HWE impossible. Among Africans, no differences were
encountered between the population studied and others an-
alyzedfortheGSTT1locus,whereasforGSTM1significant
differences (p < 0.05) were found with respect to Gambia
(0.200, Wild et al., 2000) and Egypt (0.555, Hamdy et al.,
2003). In Africa, the genetic structure of many otherwise
genetically “neutral” systems, such as mitochondrial DNA
variation, has already been demonstrated (Salas et al.,
2002).Therefore,itisnotsurprisingtodiscoverdifferences
between west and north African populations. The signifi-
cant difference in frequency of GTSM1-null alleles be-
tween the Ivory Coast, Gambian and Egyptian populations
could probably be attributed to diversity in populational
history. Moreover, data on the prevalence of various dis-
eases, especially those related to local exposure to toxic
substances, are unavailable. Therefore, among Africans it
is difficult to ascertain the cause of ethnic variation in the
frequency of “null” genotypes, and the implications there-
fromontheepidemiologicalprofilesofmetabolicdiseases.
Inconclusion,wereportedonnovelfrequencydataas
regards CYP1A1, GSTM1 and GSTT1 gene polymorphisms
in a north Ivory Coast population, thereby extending previ-
ous observations obtained from other African populations.
Although these gene polymorphisms are not neutral, and
thus cannot be used in anthropological studies as genetic
markers are subject to stochastic processes, knowledge of
their frequency distribution in the Ivory Coast could be
helpfulinunderstandingtheirrolesasgeneticsusceptibility
markers in African populations.
Acknowledgments
We would like to thank the Sisters Bruna, Anna and
Teresa, for their technical and logistic support. We also
thanktheOuangolodougoucommunityfortheirwarmwel-
come. This work was supported by grants from the “Minis-
terodell’UniversitàedellaRicercaScientifica(MURST)”.
References
Bajpai P, Tripathi AK and Agrawal D (2007) Increased frequen-
cies of glutathione-S-transferase (GSTM1 and GSTT1) null
436 CYP1A1 and GSTs in Ouangolodougou
Table 2 - Frequency of CYP1A1 and GSTs null genotypes in certain African populations.
Population n GSTM1 null frequency n GSTT1 null frequency Reference
Africans 114 0.330 114 0.250 Dandara et al. (2002)
Africans 479 0.267 Garte et al. (2001)
Egypt 200 0.555 200 0.295 Hamdy et al. (2003)
Gambia 337 0.202 326 0.371 Wild et al. (2000)
Ivory Coast 133 0.361 133 0.331 Present study
Tunisia 79 0.456 79 0.443 Ouerhani et al. (2006)
Population n Ile allele frequency Reference
Africans 114 114 0.987 Dandara et al. (2002)
Africans 445 445 0.993 Garte et al. (2001)
African-Americans 290 290 0.969 Taioli et al. (1998)
African-Americans 539 539 0.970 Garte (1998)
African-Brazilians 231 231 0.855 Gaspar et al. (2002)
African-Brazilians 21 21 0.905 Hamada et al. (1995)
Benin 94 94 1.000 Jiang et al. (2005)
Ivory Coast 133 133 0.617 Present Study
Mali 116 116 1.000 Garte (1998)
Zimbabwe 225 225 1.000 Masimirembwa et al. (1998)
n = number of tested individuals.genotypes in Indian patients with chronic myeloid leukae-
mia. Leuk Res 31:1359-1363.
Cha IH, Park JY, Chung WY, Choi MA, Kim HJ and Park KK
(2007) Polymorphisms of CYP1A1 and GSTM genes and
susceptibility to oral cancer. Yonsei Med J 48:233-239.
Chen S, Xue K, Xu L, Ma G and Wu J (2001) Polymorphisms of
theCYP1A1andGSTM1genesinrelationtoindividualsus-
ceptibility to lung carcinoma in Chinese population. Mut
Res Genom 458:41-47.
Dandara C, Savi J, Masimirembwa CM, Marimba A, Kaaya S, De
SommersK,SnymanJRandHaslerJA(2002)Geneticpoly-
morphism of cytochrome P450 1A1 (Cyp1A1) and gluta-
thione trasferases (M1, T1 and P1) among Africans. Clin
Chem Lab Med 40:952-957.
Garrigan D and Hammer MF (2006) Reconstructing human ori-
gins in the genomic era. Nat Rev Genet 7:669-680.
Garte S (1998) The role of ethnicity in cancer susceptibility gene
polymorphisms: The example of CYP1A1. Carcinogenesis
19:1329-1332.
Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H,
Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P
et al. (2001) Metabolic gene polymorphism frequencies in
controlpopulations.CancerEpidemBiomar10:1239-1248.
Gaspar PA, Kvitko K, Papadpolis LG, Hutz MH and Weimer TA
(2002) High frequency of CYP1A1*2C allele in Brazilian
populations. Hum Biol 74:235-242.
Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K
and Hunter (1998) Glutathione S-transferase GSTM1 and
GSTT1 polymorphisms and colorectal cancer risk: A pro-
spective study. Cancer Epid Biom Prev 7:1001-1005.
Hamada GS, Sugimura H, Suzuki I, Nagura K, Kiyokawa E,
Iwase T, Tanaka M, Takahashi T, Watanabe S, Kino I et al.
(1995) The heme-binding region polymorphism of cyto-
chromeP450IA1(CYP1A1),rathernthantheRsaIpolymor-
phism of IIE1 (CYPIIE1), is associated with lung cancer in
Rio de Janeiro. Cancer Epidem Biomar 4:63-67.
Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M,
Moursi N, Ahmed MS and Mizugaki M (2003) Genotype
and allele frequencies of TPMT, NAT2, GST, SULT1A1
andMDR-1intheEgyptianpopulation.BrJClinPharmacol
55:560-569.
Hatagima A, Marques CFS, Krieger E and Feitosa MF (2004)
Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1)
polymorphisms in a Brazilian mixed population. Hum Biol
76:937-942.
Indulski JA and Lutz W (2000) Metabolic genotype in relation to
individual susceptibility to environmental carcinogenesis.
Int Arch Occup Environ Health 73:71-85.
Jiang Z, Dalton TP, Jin L, Wang B, Tsuneoka Y, Shertzer HG,
Deka R and Nebert DW (2005) Toward the evaluation of
function in genetic variability: characterising human SNP
frequencies and establishing BAC-transgenic mice carrying
the human CYP1A1_CYP1A2 locus. Hum Mutat 25:196-
206.
Masimirembwa CM, Dandara C, Sommers DK, Snyman JR and
Hasler JA (1998) Genetic polymorphism of cytochrome
P4501A1, microsomal epoxide hydrolase, and glutathione
S-transferase M1 and T1 in Zimbabweans and Venda of
Southern Africa. Pharmacogenetics 8:83-85.
McGrath M, Hankinson SE and De Vivo I (2007) Cytochrome
P4501A1,cigarettesmoking,andriskofendometrialcancer
(United States). Cancer Causes Control 18:1123-1130.
Nebert DW, McKinnon RA and Puga A (1996) Human drug-
metabolizing enzyme polymorphisms: Effects on risk and
toxicity of cancer. DNA Cell Biol 15:273-280.
Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF,
Schwartz BS, Lee BK, Spitz MR, Wang M, Xu X et al.
(1995) Ethnic differences in the prevalence of the homozy-
gous deleted genotype of glutathione S-transferase theta.
Carcinogenesis 16:1243-1245.
Ouerhani S, Tebourski F, Slama MR, Marrakchi R, Rabeh M,
Hassine LB, Ayed M and Elgaaïed AB (2006) The role of
glutathione transferases M1 and T1 in individual suscepti-
bility to bladder cancer in a Tunisian population. Ann Hum
Biol 33:529-535.
Pemble S, Schroeder KR and Spenser SR (1994) Human gluta-
thione-S-transferase theta (GSTT1): cDNA cloning and the
characterization of a genetic polymorphism. Biochem J
300:271-276.
Perera FP (1997) Environment and cancer: Who are susceptible?
Science 278:1068-1073.
Raymond M and Rousset F (1995) GENEPOP v. 1.2: Population
genetics software for exact tests and ecumenicism. J Hered
86:248-249.
RoyB,MajumderPP,DeyB,ChakrabortyM,BanerjeeS,RoyM,
Mukherjee N and Sil SK (2001) Ethnic differences in distri-
butions of GSTM1 and GSTT1 homozygous “null” geno-
types in India. Hum Biol 73:443-450.
Salas A, Richards M, De la Fe T, Lareu MV, Sobrino B,
Sánchez-Diz P, Macaulay V and Carracedo A (2002) The
making of the African mtDNA landscape. Am J Hum Genet
71:1082-1111.
Taioli E, Ford J, Trachman J, Li Y, Demopoulos R and Garte S
(1998) Lung cancer risk and CYP1A1 genotype in African
Americans. Carcinogenesis 19:813-817.
Walsh PS, Metzger DA and Higuchi R (1991) Chelex 100 as a
Medium for simple extraction of DNA for PCR-based typ-
ing from forensic material. BioTechniques 10:506-513.
WildCP,YinF,TurnerPC,CheminI,ChapotB,MendyM,Whit-
tle H, Kirk GD and Hall AJ (2000) Environmental and ge-
neticdeterminantsofaflatoxin-albuminadductsintheGam-
bia. Int J Cancer 86:1-7.
Zhong S, Wyllie AH, Barnes D, Wolf CR and Spurr NK (1993).
Relationship between the GSTM1 genetic polymorphism
and susceptibility to bladder, breast and colon cancer.
Carcinogenesis 14:1821-1824.
Associate Editor: Francisco Mauro Salzano
License information: This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Santovito et al. 437